Keyword search
Filter results by
Search HelpKeyword(s)
Subject
Year of publication
Survey or statistical program
Results
All (65)
All (65) (0 to 10 of 65 results)
- Articles and reports: 82-003-X202301200002Description: The validity of survival estimates from cancer registry data depends, in part, on the identification of the deaths of deceased cancer patients. People whose deaths are missed seemingly live on forever and are informally referred to as “immortals”, and their presence in registry data can result in inflated survival estimates. This study assesses the issue of immortals in the Canadian Cancer Registry (CCR) using a recently proposed method that compares the survival of long-term survivors of cancers for which “statistical” cure has been reported with that of similar people from the general population.Release date: 2023-12-20
- Articles and reports: 82-003-X202300900002Description: According to recent Canadian estimates, over two in five Canadians will likely develop cancer in their lifetime, and one in four is expected to die of it. The lifetime probabilities of developing cancer and dying from cancer are useful summary statistics that describe the impact of cancer within a population. However, there is little information on how lifetime probabilities of developing cancer and dying from cancer have changed over time. This study aims to present detailed lifetime probabilities of developing cancer and dying from cancer by sex and cancer type, and to describe changes in these lifetime probabilities over time among the Canadian population.Release date: 2023-09-20
- Articles and reports: 82-003-X202300100001Description: Cancer survival estimates provide insights into the effectiveness of early detection and treatment. The stage of cancer at diagnosis is an important determinant of survival, reflecting the extent and spread at the time of disease detection. The recent extension of the Canadian Cancer Registry death-linked analytic file from 2014 to 2017 now offers an opportunity to provide more up-to-date net survival (NS) figures and to profile, for the first time, five-year NS estimates for Canada (excluding Quebec). This study presents five-year stage-specific cancer and five-year NS estimates for the most commonly diagnosed cancers in Canada.Release date: 2023-01-18
- Articles and reports: 82-003-X202200600002Description:
An evaluation of progress in cancer survival in Canada for all cancer types combined was recently conducted using the cancer survival index. This study provides a comprehensive evaluation of provincial-level progress in cancer survival for all cancer types combined in Canada.
Release date: 2022-06-15 - Articles and reports: 82-003-X202200300002Description:
This study presents detailed tumour-based cancer prevalence estimates in Canada by sex, age group, cancer type and prevalence duration as of January 1, 2018.
Release date: 2022-03-16 - Articles and reports: 82-003-X202100900002Description:
This study is the first comprehensive evaluation of progress in cancer survival for all cancer types combined in Canada. The results span the complete time period of the Canadian Cancer Registry and are unaffected by changes in the age, sex and case-mix of cancers over this time. Specifically, predicted Canadian net cancer survival index (CSI) estimates for the three-year period from 2015 to 2017 are presented and compared with corresponding actual estimates dating as far back as the 1992-to-1994 period. Comparisons are made for both sexes combined and for males and females separately. Further insight is provided by the determination of the most influential cancer and sex combinations and the leading cancer types within each sex, in regard to changes in the CSI since the periods of 1992 to 1994 and 2005 to 2007.
Release date: 2021-09-15 - Articles and reports: 82-003-X202100200001Description:
This study describes survival, improvement in survival over time and conditional survival for paediatric cancer patients in Canada.
Release date: 2021-02-17 - 8. Recent trends in prostate cancer in Canada ArchivedArticles and reports: 82-003-X201900400002Description:
Prostate cancer is the most common type of cancer in Canadian men. This study reports on trends in prostate cancer incidence, mortality, and stage at diagnosis in Canada from 1992 to 2015. It builds on previous Statistics Canada work by providing an up-to-date and in-depth analysis of trends in prostate cancer incidence, mortality and stage at diagnosis over time and by age group, including the impact of the updated (2014) Canadian prostate cancer screening guidelines. Data are from Statistics Canada's Canadian Cancer Registry and the Canadian Vital Statistics - Death Database Statistics Canada.
Release date: 2019-04-17 - 9. Cancer in Canada: Stage at diagnosis ArchivedArticles and reports: 82-003-X201801200003Description:
This study presents cancer incidence by stage at diagnosis for the top four cancers, using data from the Canadian Cancer Registry for the combined period of 2011 to 2015.
Release date: 2018-12-19 - Articles and reports: 82-003-X201801000001Description:
Using the 1991 and 2001 Canadian Census Health and Environment Cohorts (CanCHECs), this study examines thyroid cancer incidence over nine years of follow up; presents estimates of the sex-specific relative risk of thyroid cancer according to age, immigrant status, ethnicity, educational attainment and family income; and examines whether these relative risks changed over time.
Release date: 2018-10-17
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (65)
Analysis (65) (0 to 10 of 65 results)
- Articles and reports: 82-003-X202301200002Description: The validity of survival estimates from cancer registry data depends, in part, on the identification of the deaths of deceased cancer patients. People whose deaths are missed seemingly live on forever and are informally referred to as “immortals”, and their presence in registry data can result in inflated survival estimates. This study assesses the issue of immortals in the Canadian Cancer Registry (CCR) using a recently proposed method that compares the survival of long-term survivors of cancers for which “statistical” cure has been reported with that of similar people from the general population.Release date: 2023-12-20
- Articles and reports: 82-003-X202300900002Description: According to recent Canadian estimates, over two in five Canadians will likely develop cancer in their lifetime, and one in four is expected to die of it. The lifetime probabilities of developing cancer and dying from cancer are useful summary statistics that describe the impact of cancer within a population. However, there is little information on how lifetime probabilities of developing cancer and dying from cancer have changed over time. This study aims to present detailed lifetime probabilities of developing cancer and dying from cancer by sex and cancer type, and to describe changes in these lifetime probabilities over time among the Canadian population.Release date: 2023-09-20
- Articles and reports: 82-003-X202300100001Description: Cancer survival estimates provide insights into the effectiveness of early detection and treatment. The stage of cancer at diagnosis is an important determinant of survival, reflecting the extent and spread at the time of disease detection. The recent extension of the Canadian Cancer Registry death-linked analytic file from 2014 to 2017 now offers an opportunity to provide more up-to-date net survival (NS) figures and to profile, for the first time, five-year NS estimates for Canada (excluding Quebec). This study presents five-year stage-specific cancer and five-year NS estimates for the most commonly diagnosed cancers in Canada.Release date: 2023-01-18
- Articles and reports: 82-003-X202200600002Description:
An evaluation of progress in cancer survival in Canada for all cancer types combined was recently conducted using the cancer survival index. This study provides a comprehensive evaluation of provincial-level progress in cancer survival for all cancer types combined in Canada.
Release date: 2022-06-15 - Articles and reports: 82-003-X202200300002Description:
This study presents detailed tumour-based cancer prevalence estimates in Canada by sex, age group, cancer type and prevalence duration as of January 1, 2018.
Release date: 2022-03-16 - Articles and reports: 82-003-X202100900002Description:
This study is the first comprehensive evaluation of progress in cancer survival for all cancer types combined in Canada. The results span the complete time period of the Canadian Cancer Registry and are unaffected by changes in the age, sex and case-mix of cancers over this time. Specifically, predicted Canadian net cancer survival index (CSI) estimates for the three-year period from 2015 to 2017 are presented and compared with corresponding actual estimates dating as far back as the 1992-to-1994 period. Comparisons are made for both sexes combined and for males and females separately. Further insight is provided by the determination of the most influential cancer and sex combinations and the leading cancer types within each sex, in regard to changes in the CSI since the periods of 1992 to 1994 and 2005 to 2007.
Release date: 2021-09-15 - Articles and reports: 82-003-X202100200001Description:
This study describes survival, improvement in survival over time and conditional survival for paediatric cancer patients in Canada.
Release date: 2021-02-17 - 8. Recent trends in prostate cancer in Canada ArchivedArticles and reports: 82-003-X201900400002Description:
Prostate cancer is the most common type of cancer in Canadian men. This study reports on trends in prostate cancer incidence, mortality, and stage at diagnosis in Canada from 1992 to 2015. It builds on previous Statistics Canada work by providing an up-to-date and in-depth analysis of trends in prostate cancer incidence, mortality and stage at diagnosis over time and by age group, including the impact of the updated (2014) Canadian prostate cancer screening guidelines. Data are from Statistics Canada's Canadian Cancer Registry and the Canadian Vital Statistics - Death Database Statistics Canada.
Release date: 2019-04-17 - 9. Cancer in Canada: Stage at diagnosis ArchivedArticles and reports: 82-003-X201801200003Description:
This study presents cancer incidence by stage at diagnosis for the top four cancers, using data from the Canadian Cancer Registry for the combined period of 2011 to 2015.
Release date: 2018-12-19 - Articles and reports: 82-003-X201801000001Description:
Using the 1991 and 2001 Canadian Census Health and Environment Cohorts (CanCHECs), this study examines thyroid cancer incidence over nine years of follow up; presents estimates of the sex-specific relative risk of thyroid cancer according to age, immigrant status, ethnicity, educational attainment and family income; and examines whether these relative risks changed over time.
Release date: 2018-10-17
- Previous Go to previous page of Analysis results
- 1 (current) Go to page 1 of Analysis results
- 2 Go to page 2 of Analysis results
- 3 Go to page 3 of Analysis results
- 4 Go to page 4 of Analysis results
- 5 Go to page 5 of Analysis results
- 6 Go to page 6 of Analysis results
- 7 Go to page 7 of Analysis results
- Next Go to next page of Analysis results
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: